Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Breast Neoplasms 5Fallopian Tube Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Triple Negative Breast Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Brenner Tumor 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Rectal Neoplasms 1Pancreatic Cystic Neoplasm 1Oropharyngeal Neoplasms 1Neoplasms 1Mouth Neoplasms 1Metastatic Pancreatic Ductal Adenocarcinoma 1Locally Advanced Cervical Adenocarcinoma 1Laryngeal Neoplasms 1

Interventions

Specimen Handling 7Magnetic Resonance Spectroscopy 7Platinum 4Cisplatin 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Intensity-Modulated 3Cetuximab 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2cemiplimab 2Radiotherapy 2Radiation 2Immunoglobulin G 2Disulfides 2Carboplatin 2ipatasertib 1durvalumab 1cabozantinib 1atezolizumab 1Transurethral Resection of Bladder 1Taxes 1Radiosurgery 1Paclitaxel 1Nivolumab 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Taxes × 30 days × Clear all
NCT07195734 2026-05-19

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
180 enrolled
Head & Neck

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡